Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers
Author(s) -
Kristy A. Brown,
Neil M. Iyengar,
Xi Kathy Zhou,
Ayca Gucalp,
Kotha Subbaramaiah,
Hanhan Wang,
Dilip D. Giri,
Monica Morrow,
Domenick J. Falcone,
Nils K. Wendel,
Lisle Winston,
Michaël Pollak,
Anneloor Dierickx,
Clifford A. Hudis,
Andrew J. Dannenberg
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-3606
Subject(s) - aromatase , medicine , endocrinology , breast cancer , leptin , adiponectin , estrogen , menopause , body mass index , insulin resistance , cancer , obesity
Most estrogen-dependent breast cancers occur after menopause, despite low levels of circulating estrogens. Breast expression of the estrogen-biosynthetic enzyme, aromatase, is proposed to drive breast cancer development after menopause. However, the effects of menopause on breast aromatase expression are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom